Rabin Medical Center is a major hospital and medical center located in Petah Tikva, Israel. It is owned and operated by Clalit Health Services, Israel's largest health maintenance organization. In January 1996, Beilinson Hospital and Hasharon Hospital were merged and renamed Rabin Medical Center.

During the past decade, Rabin Medical Center conducted 468 clinical trials. In the 10-year time frame, 468 clinical trials started and 168 clinical trials were completed, i.e. on average, 35.9% percent of trials that started reached the finish line to date. In the past 5 years, 207 clinical trials started and 116 clinical trials were completed. i.e. 56% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rabin Medical Center" #1 sponsor was "Rabin Medical Center" with 157 trials, followed by "Janssen Research & Development, LLC" with 25 trials sponsored, "Pfizer" with 22 trials sponsored, "Hoffmann-La Roche" with 21 trials sponsored and "Eli Lilly and Company" with 21 trials sponsored. Other sponsors include 467 different institutions and companies that sponsored additional 273 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rabin Medical Center" #1 collaborator was "Rabin Medical Center" with 13 trials as a collaborator, "Merck Sharp & Dohme LLC" with 9 trials as a collaborator, "National Cancer Institute (NCI)" with 7 trials as a collaborator, "AstraZeneca" with 6 trials as a collaborator and "Rambam Health Care Campus" with 6 trials as a collaborator. Other collaborators include 300 different institutions and companies that were collaborators in the rest 232 trials.

According to Clinical.Site data, the most researched conditions in "Rabin Medical Center" are "Crohn's Disease" (18 trials), "Pulmonary Arterial Hypertension" (16 trials), "Prostate Cancer" (13 trials), "Breast Cancer" (11 trials) and "Carcinoma, Non-Small-Cell Lung" (10 trials). Many other conditions were trialed in "Rabin Medical Center" in a lesser frequency.

Most popular intervention types in "Rabin Medical Center" are "Drug" (465 trials), "Device" (98 trials), "Other" (86 trials), "Biological" (40 trials) and "Procedure" (34 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (139 trials), "Pembrolizumab" (21 trials), "Carboplatin" (12 trials), "Pemetrexed" (11 trials) and "Lenalidomide" (10 trials). Other intervention names were less common.

The vast majority of trials in "Rabin Medical Center" are 619 trials for "All" genders, 60 trials for "Female" genders and 36 trials for "Male" genders.

Currently, there are 219 active trials in "Rabin Medical Center". 4 are not yet recruiting, 122 are recruiting, 87 are Active, not recruiting, and 6 are Enrolling by invitation. In total, there were 287 completed trials in Rabin Medical Center, 2 suspended trials, and 73 terminated clinical trials to date.

Out of the total trials that were conducted in Rabin Medical Center, 36 "Phase 1" clinical trials were conducted, 168 "Phase 2" clinical trials and 287 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 43 trials, and there were also 125 trials that are defined as “Not Applicable".

Rabin Medical Center has several departments that took part in Clinical trials: "Rabin Medical Center; Oncology Dept" - 21 trials, "Rabin MC; Ophtalmology" - 10 trials, "Rabin Medical Center; Gastroenterology - Liver Unit" - 5 trials, "Beilinson Medical Center; Rheumatology" - 3 trials, "Urology department, Rabin Medical Center" - 2 trials, "Rabin Medical Center-Beilinson Campus;Hematology-Oncology" - 6 trials, "Cardiology Department, Rabin Medical Center" - 2 trials, "Belinson Medical Center, Division of Oncology" - 2 trials, "Rabin Medical Center-Beilinson Campus; Gaucher Clinic, Genetics Institute" - 2 trials, "Department of Otolaryngology, Rabin Medical Center" - 2 trials, "Rabin Medical Center-Beilinson Campus, Pulmonary Institute, 39 Jabotinsky St Ground floor" - 2 trials, "Beilinson Medical Center; Pulmonary Inst." - 2 trials